ClinicalTrials.gov
ClinicalTrials.gov Menu

Reference Intervals for Sonoclot Analysis in Chinese

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01759433
Recruitment Status : Completed
First Posted : January 3, 2013
Last Update Posted : December 31, 2013
Sponsor:
Information provided by (Responsible Party):
Zhenlu Zhang, Wuhan Asia Heart Hospital

Brief Summary:
The reference intervals for Sonoclot Analysis may be different between Chinese and American. So far, no reference interval has been established in Chinese for Sonoclot Analysis. This study is going to establish the first Chinese reference intervals for Sonoclot Analysis and test whether they are different from American reference intervals.

Condition or disease
Cardiovascular Diseases

Study Type : Observational
Actual Enrollment : 135 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Reference Ranges for Sonoclot Analysis in Chinese
Study Start Date : December 2012
Actual Primary Completion Date : March 2013
Actual Study Completion Date : March 2013



Primary Outcome Measures :
  1. The reference intervals for sonoclot analysis in Chinese [ Time Frame: 3 month ]
    whether Chinese reference intervals are different from Caucasian reference intervals.


Biospecimen Retention:   None Retained
2.7 mL citrated blood.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Chinese healthy adults aged 18 and older
Criteria

Inclusion Criteria:

  • Aged 18 and older
  • Han ethnic

Exclusion Criteria:

  • Renal dysfunction
  • Liver disorders
  • Known coagulation disorders
  • Patients taking medications in the last month

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01759433


Locations
China, Hubei
Wuhan Asia Heart hospital
Wuhan, Hubei, China, 430022
Sponsors and Collaborators
Wuhan Asia Heart Hospital

Responsible Party: Zhenlu Zhang, Director of the clinical laboratory, Wuhan Asia Heart Hospital
ClinicalTrials.gov Identifier: NCT01759433     History of Changes
Other Study ID Numbers: SCWH001
First Posted: January 3, 2013    Key Record Dates
Last Update Posted: December 31, 2013
Last Verified: December 2013

Additional relevant MeSH terms:
Cardiovascular Diseases